Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Inogen Inc
Report date September 17, 2018 · Filed September 19, 2018
Section 16 reporting ended · disclosed 2018-09-19. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 5,595 |
Ending reported balance
After 2018-09-17 transaction · row 8
8 source rows · reconciled sequenceRow 1 · 2018-09-17 · Exercise / conversion · Acquired 2,000 · Balance 7,595 Row 2 · 2018-09-17 · Sale · Disposed 386 · Balance 7,209 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2018. F2: Represents the weighted average share price of an aggregate total of 386 shares sold in the price range of $275.22 to $276.20 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Row 3 · 2018-09-17 · Sale · Disposed 200 · Balance 7,009 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2018. F3: Represents the weighted average share price of an aggregate total of 200 shares sold in the price range of $276.45 to $276.78 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Row 4 · 2018-09-17 · Sale · Disposed 100 · Balance 6,909 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2018. Row 5 · 2018-09-17 · Sale · Disposed 100 · Balance 6,809 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2018. Row 6 · 2018-09-17 · Sale · Disposed 600 · Balance 6,209 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2018. F4: Represents the weighted average share price of an aggregate total of 600 shares sold in the price range of $282.92 to $283.75 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Row 7 · 2018-09-17 · Sale · Disposed 500 · Balance 5,709 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2018. F5: Represents the weighted average share price of an aggregate total of 500 shares sold in the price range of $284.48 to $285.34 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Row 8 · 2018-09-17 · Sale · Disposed 114 · Balance 5,595 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2018. F6: Represents the weighted average share price of an aggregate total of 114 shares sold in the price range of $285.80 to $285.90 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.81 · Expires 2022-03-28 | Direct | 5,683 |
Reported balance
After 2018-09-17 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2018-09-17 · Exercise / conversion · Disposed 2,000 · Balance 5,683 F7: Subject to the reporting person's continuing service, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is April 1, 2012. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2018.
F2: Represents the weighted average share price of an aggregate total of 386 shares sold in the price range of $275.22 to $276.20 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3: Represents the weighted average share price of an aggregate total of 200 shares sold in the price range of $276.45 to $276.78 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F4: Represents the weighted average share price of an aggregate total of 600 shares sold in the price range of $282.92 to $283.75 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F5: Represents the weighted average share price of an aggregate total of 500 shares sold in the price range of $284.48 to $285.34 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F6: Represents the weighted average share price of an aggregate total of 114 shares sold in the price range of $285.80 to $285.90 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F7: Subject to the reporting person's continuing service, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is April 1, 2012.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 17, 2018 Filed Sep 19, 2018 22:41 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 2,000 | $0.00 Strike: $0.81 | $0.00 |
DisclosureSEC source: 0001209191-18-051693 · doc4.xml · derivative · entry 9 Scribner Matt · CIK 0001596087 · Former Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,683 Underlying: Common Stock · 2,000 shares Expires 2022-03-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Subject to the reporting person's continuing service, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is April 1, 2012. Read SEC document |
| September 17, 2018 Filed Sep 19, 2018 22:41 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 114 | $285.81 | $32,582.60 |
DisclosureSEC source: 0001209191-18-051693 · doc4.xml · nonDerivative · entry 8 Scribner Matt · CIK 0001596087 · Former Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,595 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2018. F6 · price: Represents the weighted average share price of an aggregate total of 114 shares sold in the price range of $285.80 to $285.90 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 17, 2018 Filed Sep 19, 2018 22:41 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 500 | $284.89 | $142,443.00 |
DisclosureSEC source: 0001209191-18-051693 · doc4.xml · nonDerivative · entry 7 Scribner Matt · CIK 0001596087 · Former Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,709 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2018. F5 · price: Represents the weighted average share price of an aggregate total of 500 shares sold in the price range of $284.48 to $285.34 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 17, 2018 Filed Sep 19, 2018 22:41 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 600 | $283.17 | $169,902.00 |
DisclosureSEC source: 0001209191-18-051693 · doc4.xml · nonDerivative · entry 6 Scribner Matt · CIK 0001596087 · Former Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,209 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2018. F4 · price: Represents the weighted average share price of an aggregate total of 600 shares sold in the price range of $282.92 to $283.75 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 17, 2018 Filed Sep 19, 2018 22:41 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 100 | $280.04 | $28,004.00 |
DisclosureSEC source: 0001209191-18-051693 · doc4.xml · nonDerivative · entry 5 Scribner Matt · CIK 0001596087 · Former Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,809 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2018. Read SEC document |
| September 17, 2018 Filed Sep 19, 2018 22:41 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 100 | $277.49 | $27,749.00 |
DisclosureSEC source: 0001209191-18-051693 · doc4.xml · nonDerivative · entry 4 Scribner Matt · CIK 0001596087 · Former Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,909 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2018. Read SEC document |
| September 17, 2018 Filed Sep 19, 2018 22:41 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 200 | $276.62 | $55,323.00 |
DisclosureSEC source: 0001209191-18-051693 · doc4.xml · nonDerivative · entry 3 Scribner Matt · CIK 0001596087 · Former Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,009 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2018. F3 · price: Represents the weighted average share price of an aggregate total of 200 shares sold in the price range of $276.45 to $276.78 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 17, 2018 Filed Sep 19, 2018 22:41 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 386 | $275.78 | $106,450.12 |
DisclosureSEC source: 0001209191-18-051693 · doc4.xml · nonDerivative · entry 2 Scribner Matt · CIK 0001596087 · Former Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,209 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2018. F2 · price: Represents the weighted average share price of an aggregate total of 386 shares sold in the price range of $275.22 to $276.20 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 17, 2018 Filed Sep 19, 2018 22:41 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 2,000 | $0.81 | $1,620.00 |
DisclosureSEC source: 0001209191-18-051693 · doc4.xml · nonDerivative · entry 1 Scribner Matt · CIK 0001596087 · Former Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,595 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2018 Filed Sep 5, 2018 20:36 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 279 | $264.91 | $73,909.89 |
DisclosureSEC source: 0001209191-18-049577 · doc4.xml · nonDerivative · entry 1 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,595 F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on September 1, 2018. Read SEC document |
| April 16, 2018 Filed Apr 18, 2018 01:28 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 2,500 | $0.00 Strike: $0.81 | $0.00 |
DisclosureSEC source: 0001209191-18-025277 · doc4.xml · derivative · entry 4 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,683 Underlying: Common Stock · 2,500 shares Expires 2022-03-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Subject to the reporting person's continuing service, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is April 1, 2012. Read SEC document |
| April 16, 2018 Filed Apr 18, 2018 01:28 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 500 | $140.64 | $70,319.00 |
DisclosureSEC source: 0001209191-18-025277 · doc4.xml · nonDerivative · entry 3 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,874 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2016. F3 · price: Represents the weighted average share price of an aggregate total of 500 shares sold in the price range of $140.43 to $141.03 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| April 16, 2018 Filed Apr 18, 2018 01:28 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 2,000 | $139.57 | $279,146.00 |
DisclosureSEC source: 0001209191-18-025277 · doc4.xml · nonDerivative · entry 2 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,374 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2016. F2 · price: Represents the weighted average share price of an aggregate total of 2,000 shares sold in the price range of $139.32 to $139.89 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price Read SEC document |
| April 16, 2018 Filed Apr 18, 2018 01:28 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 2,500 | $0.81 | $2,025.00 |
DisclosureSEC source: 0001209191-18-025277 · doc4.xml · nonDerivative · entry 1 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,374 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2018 Filed Mar 19, 2018 23:50 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 2,500 | $0.00 Strike: $0.81 | $0.00 |
DisclosureSEC source: 0001209191-18-020752 · doc4.xml · derivative · entry 6 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,183 Underlying: Common Stock · 2,500 shares Expires 2022-03-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Subject to the reporting person's continuing service, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is April 1, 2012. Read SEC document |
| March 15, 2018 Filed Mar 19, 2018 23:50 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 55 | $129.45 | $7,119.65 |
DisclosureSEC source: 0001209191-18-020752 · doc4.xml · nonDerivative · entry 5 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,874 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2016. F5 · price: Represents the weighted average share price of an aggregate total of 55 shares sold in the price range of $129.40 to $129.45 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F1 · balance_after: Amount includes 10 shares that were inadvertently omitted from the reporting person's previous Forms 4 filed on February 16, 2018, March 2, 2018, and March 6, 2018, due to a clerical error. Read SEC document |
| March 15, 2018 Filed Mar 19, 2018 23:50 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 845 | $128.69 | $108,740.60 |
DisclosureSEC source: 0001209191-18-020752 · doc4.xml · nonDerivative · entry 4 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,929 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2016. F4 · price: Represents the weighted average share price of an aggregate total of 845 shares sold in the price range of $128.29 to $129.08 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F1 · balance_after: Amount includes 10 shares that were inadvertently omitted from the reporting person's previous Forms 4 filed on February 16, 2018, March 2, 2018, and March 6, 2018, due to a clerical error. Read SEC document |
| March 15, 2018 Filed Mar 19, 2018 23:50 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 1,527 | $127.58 | $194,816.65 |
DisclosureSEC source: 0001209191-18-020752 · doc4.xml · nonDerivative · entry 3 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,774 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2016. F3 · price: Represents the weighted average share price of an aggregate total of 1,527 shares sold in the price range of $127.06 to $128.01 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F1 · balance_after: Amount includes 10 shares that were inadvertently omitted from the reporting person's previous Forms 4 filed on February 16, 2018, March 2, 2018, and March 6, 2018, due to a clerical error. Read SEC document |
| March 15, 2018 Filed Mar 19, 2018 23:50 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 73 | $125.94 | $9,193.62 |
DisclosureSEC source: 0001209191-18-020752 · doc4.xml · nonDerivative · entry 2 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,301 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2016. F1 · balance_after: Amount includes 10 shares that were inadvertently omitted from the reporting person's previous Forms 4 filed on February 16, 2018, March 2, 2018, and March 6, 2018, due to a clerical error. Read SEC document |
| March 15, 2018 Filed Mar 19, 2018 23:50 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 2,500 | $0.81 | $2,025.00 |
DisclosureSEC source: 0001209191-18-020752 · doc4.xml · nonDerivative · entry 1 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,374 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Amount includes 10 shares that were inadvertently omitted from the reporting person's previous Forms 4 filed on February 16, 2018, March 2, 2018, and March 6, 2018, due to a clerical error. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 22:50 UTC | Inogen Inc INGN · Entity 2083 | GrantCommon Stock | 614 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-017412 · doc4.xml · nonDerivative · entry 1 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,864 F1 · shares: The reported securities represent shares of restricted stock, 25% of which shall vest on March 1, 2019, and 1/16th of which shall vest every three months thereafter on the 1st day of the month, subject in each case to the reporting person remaining a service provider through each such applicable vesting date. Read SEC document |
| March 01, 2018 Filed Mar 2, 2018 22:55 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 247 | $118.33 | $29,227.51 |
DisclosureSEC source: 0001209191-18-015943 · doc4.xml · nonDerivative · entry 2 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,250 F2 · shares: The reported shares were withheld in a net issuance to cover the Reporting Person's tax withholding liability in connection with the portion of the 2017 performance-based restricted stock award that was earned and vested on March 1, 2018. Read SEC document |
| March 01, 2018 Filed Mar 2, 2018 22:55 UTC | Inogen Inc INGN · Entity 2083 | GrantCommon Stock | 710 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-015943 · doc4.xml · nonDerivative · entry 1 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,497 F1 · shares: The reported securities represent shares earned and vested on March 1, 2018 based on achievement of the financial performance conditions for the 2017 fiscal year that were approved as part of the 2017 performance-based restricted stock award granted on August 8, 2017 Read SEC document |
| February 15, 2018 Filed Feb 16, 2018 22:19 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 2,500 | $0.00 Strike: $0.81 | $0.00 |
DisclosureSEC source: 0001209191-18-010929 · doc4.xml · derivative · entry 4 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,683 Underlying: Common Stock · 2,500 shares Expires 2022-03-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Subject to the reporting person's continuing service, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is April 1, 2012. Read SEC document |
| February 15, 2018 Filed Feb 16, 2018 22:19 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 100 | $120.00 | $12,000.00 |
DisclosureSEC source: 0001209191-18-010929 · doc4.xml · nonDerivative · entry 3 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,787 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2016. Read SEC document |
| February 15, 2018 Filed Feb 16, 2018 22:19 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 2,400 | $119.24 | $286,172.88 |
DisclosureSEC source: 0001209191-18-010929 · doc4.xml · nonDerivative · entry 2 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,897 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2016. F2 · price: Represents the weighted average share price of an aggregate total of 2,400 shares sold in the price range of $118.80 to $119.65 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 15, 2018 Filed Feb 16, 2018 22:19 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 2,500 | $0.81 | $2,025.00 |
DisclosureSEC source: 0001209191-18-010929 · doc4.xml · nonDerivative · entry 1 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,297 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 16, 2018 Filed Jan 18, 2018 21:52 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 2,500 | $0.00 Strike: $0.81 | $0.00 |
DisclosureSEC source: 0001209191-18-004284 · doc4.xml · derivative · entry 3 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,183 Underlying: Common Stock · 2,500 shares Expires 2022-03-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Subject to the reporting person's continuing service, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is April 1, 2012. Read SEC document |
| January 16, 2018 Filed Jan 18, 2018 21:52 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 2,500 | $116.17 | $290,418.00 |
DisclosureSEC source: 0001209191-18-004284 · doc4.xml · nonDerivative · entry 2 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,797 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2016. F2 · price: Represents the weighted average share price of an aggregate total of 2,500 shares sold in the price range of $115.68 to $116.57 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 16, 2018 Filed Jan 18, 2018 21:52 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 2,500 | $0.81 | $2,025.00 |
DisclosureSEC source: 0001209191-18-004284 · doc4.xml · nonDerivative · entry 1 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,297 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 14, 2017 Filed Dec 15, 2017 22:54 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 2,500 | $0.00 Strike: $0.81 | $0.00 |
DisclosureSEC source: 0001209191-17-066047 · doc4.xml · derivative · entry 4 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,683 Underlying: Common Stock · 2,500 shares Expires 2022-03-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Subject to the reporting person's continuing service, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is April 1, 2012. Read SEC document |
| December 14, 2017 Filed Dec 15, 2017 22:54 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 321 | $121.15 | $38,889.63 |
DisclosureSEC source: 0001209191-17-066047 · doc4.xml · nonDerivative · entry 3 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,797 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2016. F3 · price: Represents the weighted average share price of an aggregate total of 321 shares sold in the price range of $120.99 to $121.490 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price Read SEC document |
| December 14, 2017 Filed Dec 15, 2017 22:54 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 2,179 | $120.23 | $261,970.28 |
DisclosureSEC source: 0001209191-17-066047 · doc4.xml · nonDerivative · entry 2 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,118 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2016. F2 · price: Represents the weighted average share price of an aggregate total of 2,179 shares sold in the price range of $119.90 to $120.88 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| December 14, 2017 Filed Dec 15, 2017 22:54 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 2,500 | $0.81 | $2,025.00 |
DisclosureSEC source: 0001209191-17-066047 · doc4.xml · nonDerivative · entry 1 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,297 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 27, 2017 Filed Nov 29, 2017 22:14 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 333 | $0.00 Strike: $2.40 | $0.00 |
DisclosureSEC source: 0001209191-17-062880 · doc4.xml · derivative · entry 2 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 333 shares Expires 2018-03-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Subject to the reporting person's continuing service, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is January 1, 2008. Read SEC document |
| November 27, 2017 Filed Nov 29, 2017 22:14 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 333 | $2.40 | $799.20 |
DisclosureSEC source: 0001209191-17-062880 · doc4.xml · nonDerivative · entry 1 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,797 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 13, 2017 Filed Nov 15, 2017 21:08 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 819 | $0.00 Strike: $0.81 | $0.00 |
DisclosureSEC source: 0001209191-17-060860 · doc4.xml · derivative · entry 6 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,183 Underlying: Common Stock · 819 shares Expires 2022-03-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Subject to the reporting person's continuing service, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is April 1, 2012. Read SEC document |
| November 13, 2017 Filed Nov 15, 2017 21:08 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 1,681 | $0.00 Strike: $0.75 | $0.00 |
DisclosureSEC source: 0001209191-17-060860 · doc4.xml · derivative · entry 5 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,681 shares Expires 2021-10-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Subject to the reporting person's continuing service, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is August 1, 2011. Read SEC document |
| November 13, 2017 Filed Nov 15, 2017 21:08 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 300 | $113.63 | $34,089.00 |
DisclosureSEC source: 0001209191-17-060860 · doc4.xml · nonDerivative · entry 4 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,464 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2016. Read SEC document |
| November 13, 2017 Filed Nov 15, 2017 21:08 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 2,200 | $112.17 | $246,782.80 |
DisclosureSEC source: 0001209191-17-060860 · doc4.xml · nonDerivative · entry 3 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,764 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2016. F2 · price: Represents the weighted average share price of an aggregate total of 2,200 shares sold in the price range of $111.83 to $112.76 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 13, 2017 Filed Nov 15, 2017 21:08 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 819 | $0.81 | $663.39 |
DisclosureSEC source: 0001209191-17-060860 · doc4.xml · nonDerivative · entry 2 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,964 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 13, 2017 Filed Nov 15, 2017 21:08 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 1,681 | $0.75 | $1,260.75 |
DisclosureSEC source: 0001209191-17-060860 · doc4.xml · nonDerivative · entry 1 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,145 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 12, 2017 Filed Oct 13, 2017 22:16 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 2,500 | $0.00 Strike: $0.75 | $0.00 |
DisclosureSEC source: 0001209191-17-056928 · doc4.xml · derivative · entry 3 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,681 Underlying: Common Stock · 2,500 shares Expires 2021-10-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Subject to the reporting person's continuing service, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is August 1, 2011. Read SEC document |
| October 12, 2017 Filed Oct 13, 2017 22:16 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 2,500 | $93.88 | $234,712.25 |
DisclosureSEC source: 0001209191-17-056928 · doc4.xml · nonDerivative · entry 2 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,464 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2016. F2 · price: Represents the weighted average share price of an aggregate total of 2,500 shares sold in the price range of $93.3250 to $94.3000 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| October 12, 2017 Filed Oct 13, 2017 22:16 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 2,500 | $0.75 | $1,875.00 |
DisclosureSEC source: 0001209191-17-056928 · doc4.xml · nonDerivative · entry 1 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,964 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 11, 2017 Filed Sep 12, 2017 22:19 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 2,500 | $0.00 Strike: $0.75 | $0.00 |
DisclosureSEC source: 0001209191-17-052482 · doc4.xml · derivative · entry 3 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,181 Underlying: Common Stock · 2,500 shares Expires 2021-10-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Subject to the reporting person's continuing service, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is August 1, 2011. Read SEC document |
| September 11, 2017 Filed Sep 12, 2017 22:19 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 2,500 | $103.23 | $258,084.75 |
DisclosureSEC source: 0001209191-17-052482 · doc4.xml · nonDerivative · entry 2 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,464 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2016. F2 · price: Represents the weighted average share price of an aggregate total of 2,500 shares sold in the price range of $102.76 to $103.73 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 11, 2017 Filed Sep 12, 2017 22:19 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 2,500 | $0.75 | $1,875.00 |
DisclosureSEC source: 0001209191-17-052482 · doc4.xml · nonDerivative · entry 1 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,964 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 18, 2017 Filed Aug 22, 2017 20:19 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 2,500 | $0.00 Strike: $0.75 | $0.00 |
DisclosureSEC source: 0001209191-17-049819 · doc4.xml · derivative · entry 3 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,681 Underlying: Common Stock · 2,500 shares Expires 2021-10-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Subject to the reporting person's continuing service, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is August 1, 2011. Read SEC document |
| August 18, 2017 Filed Aug 22, 2017 20:19 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 2,500 | $92.45 | $231,119.00 |
DisclosureSEC source: 0001209191-17-049819 · doc4.xml · nonDerivative · entry 2 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,464 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2016. F2 · price: Represents the weighted average share price of an aggregate total of 2,500 shares sold in the price range of $92.25 to $92.76 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.